A tweetorial summary….
https://twitter.com/cleversloth_/status/1336792524111949828?s=20
https://twitter.com/cleversloth_/status/1336792524111949828?s=20
Watch the interview in the VOD section but here is a tweetorial summarising the discussion. I’ve included the key references…
Jerry Nolan now being interviewed on all things cardiac arrest – starting with adrenaline.
He also gives a very good talk on the myths.
Blog summary found on https://t.co/007aaqP7wo#LIVES2020
— Adrian Wong (@avkwong) December 9, 2020
Pr Alexandre DEMOULE
ARDS pts should be intubated promptly
Time to intubation has no impact on mortality
In COPD, NIV is contrainidcated in case of coma
In cancer pts, do everything not to intubate
Response to PRONE position predicts the outcome
Prof J Bakker
The ten pitfalls of lactate clearance in sepsis
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock
The ANDROMEDA-SHOCK Randomized Clinical Trial
Conclusions
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest
Conclusion
J De Weale (twitter)
The FALSE beliefs
Summary
Prof’s De Weale’s slideset (I like the design)
Prof Mihaela van der Schaar (twitter) www.vanderschaar-lab.com
Machine learning can enable:
1) Delivering precision medicine at the patient level
2) Understanding the basis and trajectories of health and disease
3) Informing and improving clinical pathways, better utilize resources, and reduce costs
4) Transforming population health and public health policy
F Schortgen
Fever is not hyperthermia
Treating fever has never been proven to improve patient comfort
Antipyresis is NOT necessarily good for haemodynamic stabilistation and tissue oxygenation
Prof S Price
COVID-19
Clinical application of the 4th Universal Definition of Myocardial Infarction
Temporary circulatory support for cardiogenic shock
EJ Nossent
Potential therapies
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Take home message
From the disease lung fibrosis to criteria, towards phenotyping, towards personalized medicine.
Prof S Koch
COVID-19
Conclusion
EID risk is increasing due to climate change and loss of biodiversity
-> we need to adress this now
Neurological manifestation of Covid-19 occur in ~ 36%
Cerebrovasculare Manifestions occur in ~ 5% of Covid-19 patients based on
–pathological coagulation or hyperinflammation
–includes younger patients or patients with typical riskfactors
–leads to more severe outcome
-> check carefully coagulation parameters and risk factors
Altered conscious state is seen in ~ 65% of Covid-19 ICU patients
–based on encephalopathy or seizures
-> EEG monitoring, MRI
S Loer
Optimizing preoperative fluid therapy Encourage use of clear carbohydrate drinks up until 2 h prior to surgery!
Intraoperative fluids
Anesthesia-induced immune modulation
Post-op delirium
Postoperative delirium: perioperative assessment, risk reduction, and management
Post-op pain